Fig. 6

The global prevalence of neuroblastoma and peripheral nervous system tumours among individuals aged 60 years and older across 204 countries and territories: age-standardised prevalence rate in 2021 (A), number of prevalent cases in 2021 (B), and the EAPC in prevalence from 1990 to 2021 (C). EAPC, Estimated Average Percentage Change